HoLEP represents a valid alternative to both transurethral resection of the prostate and open prostatectomy for treatment of patients suffering from lower urinary tract symptoms due to benign prostatic enlargement. The recently published long-term follow-up data demonstrate the durability of functional results. HoLEP can be offered as the size-independent gold standard treatment of patients with lower urinary tract symptoms because of benign prostatic enlargement.
No takes yet. Share an insight, caveat, or question.
Suardi et al. (2008) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: